These hydrolysates exhibited dual functionality: direct ROS scavenging and activation of antioxidant enzymes (SOD, CAT, GSH-Px) in oxidative-stressed HUVECs at 200 μg/mL, demonstrated therapeutic potential for metabolic disorders. The gene discussed is SOD1; the disease is metabolic disease.